Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pcDNA3-HA-ADH Citations (5)

Originally described in: Johnson Lab Plasmids
Unpublished

Articles Citing pcDNA3-HA-ADH

Articles
Phosphorylation-dependent regulation of ALDH1A1 by Aurora kinase A: insights on their synergistic relationship in pancreatic cancer. Wang J, Nikhil K, Viccaro K, Chang L, White J, Shah K. BMC Biol. 2017 Feb 13;15(1):10. doi: 10.1186/s12915-016-0335-5. PubMed
Targeted therapy for a subset of acute myeloid leukemias that lack expression of aldehyde dehydrogenase 1A1. Gasparetto M, Pei S, Minhajuddin M, Khan N, Pollyea DA, Myers JR, Ashton JM, Becker MW, Vasiliou V, Humphries KR, Jordan CT, Smith CA. Haematologica. 2017 Jun;102(6):1054-1065. doi: 10.3324/haematol.2016.159053. Epub 2017 Mar 9. PubMed
Mutant p53 gain of function underlies high expression levels of colorectal cancer stem cells markers. Solomon H, Dinowitz N, Pateras IS, Cooks T, Shetzer Y, Molchadsky A, Charni M, Rabani S, Koifman G, Tarcic O, Porat Z, Kogan-Sakin I, Goldfinger N, Oren M, Harris CC, Gorgoulis VG, Rotter V. Oncogene. 2018 Mar;37(12):1669-1684. doi: 10.1038/s41388-017-0060-8. Epub 2018 Jan 18. PubMed
The SOX9-Aldehyde Dehydrogenase Axis Determines Resistance to Chemotherapy in Non-Small-Cell Lung Cancer. Voronkova MA, Rojanasakul LW, Kiratipaiboon C, Rojanasakul Y. Mol Cell Biol. 2020 Jan 3;40(2). pii: MCB.00307-19. doi: 10.1128/MCB.00307-19. Print 2020 Jan 3. PubMed
Loss of PBRM1 Alters Promoter Histone Modifications and Activates ALDH1A1 to Drive Renal Cell Carcinoma. Schoenfeld DA, Zhou R, Zairis S, Su W, Steinbach N, Mathur D, Bansal A, Zachem AL, Tavarez B, Hasson D, Bernstein E, Rabadan R, Parsons R. Mol Cancer Res. 2022 Aug 5;20(8):1193-1207. doi: 10.1158/1541-7786.MCR-21-1039. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.